INSILICO expands share capital by 0.53% through option exercises and award vesting

Bulletin Express

Jul 06

InSilico Medicine Cayman TopCo (INSILICO, HKEx: 03696) reported a 0.53% increase in its issued share capital following the allotment of 3.05 million new ordinary shares between 2 July and 6 July 2026.

Key data

• Opening share count (30 Jun 2026): 575.84 million shares.

• New shares issued under Pre-IPO Equity Incentive Plans: – 02 Jul: 0.76 million shares at HKD 6.3493 each (non-director option exercise). – 03 Jul: 0.29 million shares at HKD 7.9331 each (non-director option exercise). – 06 Jul: 0.40 million shares at HKD 9.9163 each (non-director option exercise). – 06 Jul: 1.60 million shares at nil consideration (director share-award vesting).

• Closing share count (06 Jul 2026): 578.89 million shares.

No treasury shares were held, repurchased, or cancelled during the period, and the board confirmed full compliance with Hong Kong listing and regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1169879565"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169879565\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169879565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169879565","market":"us","top_or_hot":-1,"title":"INSILICO expands share capital by 0.53% through option exercises and award vesting","media":"Bulletin Express","content":"<p>InSilico Medicine Cayman TopCo (INSILICO, HKEx: 03696) reported a 0.53% increase in its issued share capital following the allotment of 3.05 million new ordinary shares between 2 July and 6 July 2026.</p>\n<p>Key data</p>\n<p>• Opening share count (30 Jun 2026): 575.84 million shares.</p>\n<p>• New shares issued under Pre-IPO Equity Incentive Plans:  \n – 02 Jul: 0.76 million shares at HKD 6.3493 each (non-director option exercise).  \n – 03 Jul: 0.29 million shares at HKD 7.9331 each (non-director option exercise).  \n – 06 Jul: 0.40 million shares at HKD 9.9163 each (non-director option exercise).  \n – 06 Jul: 1.60 million shares at nil consideration (director share-award vesting).</p>\n<p>• Closing share count (06 Jul 2026): 578.89 million shares.</p>\n<p>No treasury shares were held, repurchased, or cancelled during the period, and the board confirmed full compliance with Hong Kong listing and regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INSILICO expands share capital by 0.53% through option exercises and award vesting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINSILICO expands share capital by 0.53% through option exercises and award vesting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-06 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InSilico Medicine Cayman TopCo (INSILICO, HKEx: 03696) reported a 0.53% increase in its issued share capital following the allotment of 3.05 million new ordinary shares between 2 July and 6 July 2026.</p>\n<p>Key data</p>\n<p>• Opening share count (30 Jun 2026): 575.84 million shares.</p>\n<p>• New shares issued under Pre-IPO Equity Incentive Plans:  \n – 02 Jul: 0.76 million shares at HKD 6.3493 each (non-director option exercise).  \n – 03 Jul: 0.29 million shares at HKD 7.9331 each (non-director option exercise).  \n – 06 Jul: 0.40 million shares at HKD 9.9163 each (non-director option exercise).  \n – 06 Jul: 1.60 million shares at nil consideration (director share-award vesting).</p>\n<p>• Closing share count (06 Jul 2026): 578.89 million shares.</p>\n<p>No treasury shares were held, repurchased, or cancelled during the period, and the board confirmed full compliance with Hong Kong listing and regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1169879565","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169879565","pubTimestamp":1783349022,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InSilico Medicine Cayman TopCo (INSILICO, HKEx: 03696) reported a 0.53% increase in its issued share capital following the allotment of 3.05 million new ordinary shares between 2 July and 6 July...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"英矽智能通过期权行使和奖励归属将股本扩大0.53%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"InSilico Medicine Cayman TopCo (INSILICO, HKEx: 03696) reported a 0.53% increase in its issued share capital following the allotment of 3.05 million new ordinary shares between 2 July and 6 July 2026.\nKey data\n• Opening share count (30 Jun 2026): 575.84 million shares.\n• New shares issued under Pre-IPO Equity Incentive Plans:  \n – 02 Jul: 0.76 million shares at HKD 6.3493 each (non-director option exercise).  \n – 03 Jul: 0.29 million shares at HKD 7.9331 each (non-director option exercise).  \n – 06 Jul: 0.40 million shares at HKD 9.9163 each (non-director option exercise).  \n – 06 Jul: 1.60 million shares at nil consideration (director share-award vesting).\n• Closing share count (06 Jul 2026): 578.89 million shares.\nNo treasury shares were held, repurchased, or cancelled during the period, and the board confirmed full compliance with Hong Kong listing and regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}